Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (BMY) Revenue
Annual & quarterly revenue history · segment & region breakdown
BMY · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBristol-Myers Squibb Company trailing twelve-month (TTM) revenue is $48.48B, a decrease of 0.22% year-over-year from $48.19B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $48.19B | -$0.11B | -0.22% |
| 2024-12-31 | $48.30B | +$3.29B | +7.32% |
| 2023-12-31 | $45.01B | -$1.15B | -2.50% |
| 2022-12-31 | $46.16B | -$0.23B | -0.49% |
| 2021-12-31 | $46.38B | +$3.87B | +9.09% |
| 2020-12-31 | $42.52B | +$16.37B | +62.62% |
| 2019-12-31 | $26.14B | +$3.58B | +15.89% |
| 2018-12-31 | $22.56B | +$1.78B | +8.59% |
| 2017-12-31 | $20.78B | +$1.35B | +6.94% |
| 2016-12-31 | $19.43B | +$2.87B | +17.31% |
Compare revenue vs peers
Drug Manufacturers - GeneralCompare BMY revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Bristol-Myers Squibb Company receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Bristol-Myers Squibb Company reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Bristol-Myers Squibb Company's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BMY revenue · 4 questionsBMY's trailing twelve-month (TTM) revenue is $48.48B. That is a decrease of 0.22% year-over-year from $48.19B in FY2025.
▸ Source: FMP · Bristol-Myers Squibb Company SEC filings · GAAP · Bristol-Myers Squibb Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026